Immunological response in mice bearing LM3 breast tumor undergoing Pulchellin treatment
<p>Abstract</p> <p>Background</p> <p>Ribosome-inactivating proteins (RIP) have been studied in the search for toxins that could be used as immunotoxins for cancer treatment. Pulchellin, a type 2 RIP, is suggested to induce immune responses that have a role in controllin...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | BMC Complementary and Alternative Medicine |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1472-6882/12/107 |